TY - JOUR
T1 - Homocysteine-induced impairment of insulin secretion from clonal pancreatic BRIN-BD11 β-cells is not prevented by catalase
AU - Patterson, Steven
AU - Flatt, Peter R.
AU - McClenaghan, Neville H.
PY - 2007/1
Y1 - 2007/1
N2 - OBJECTIVES: Although detrimental effects of homocysteine attributed to homocysteine auto-oxidation and generation of hydrogen peroxide (H2O2) have been reported in various cell types, such actions have not been considered in pancreatic β-cells. This study investigates the acute effects of homocysteine on β-cell integrity and regulation, in particular, the role of H2O2 generated by auto-oxidation. METHODS: Assessment of β-cell function was examined during acute 20- or 40-minute incubations with homocysteine using clonal BRIN-BD11 β-cells. RESULTS: Homocysteine (50-1000 μmol/L) inhibited basal and glucose-induced insulin secretion in a concentration- dependent manner. Insulinotropic responses to alanine, arginine, 2-ketoisocaproate, elevated Ca, tolbutamide, potassium chloride (KCl), forskolin, and phorbol 12-myristate 13-acetate were also significantly reduced by homocysteine. Likewise, preincubation with homocysteine caused a reduction in the insulinotropic responses to glucose and each of the secretagogues tested. Notably, excess catalase (100 μg/mL) in the buffer, although sufficient to remove homocysteine-derived H2O2, did not alleviate the detrimental effects of homocysteine. CONCLUSIONS: Collectively, these data suggest that homocysteine impairs insulin secretory function by mechanisms independent of H2O2 generation. Although homocysteine may give rise to reactive oxygen species, these observations indicate detrimental non-oxidative pancreatic β-cell actions of homocysteine.
AB - OBJECTIVES: Although detrimental effects of homocysteine attributed to homocysteine auto-oxidation and generation of hydrogen peroxide (H2O2) have been reported in various cell types, such actions have not been considered in pancreatic β-cells. This study investigates the acute effects of homocysteine on β-cell integrity and regulation, in particular, the role of H2O2 generated by auto-oxidation. METHODS: Assessment of β-cell function was examined during acute 20- or 40-minute incubations with homocysteine using clonal BRIN-BD11 β-cells. RESULTS: Homocysteine (50-1000 μmol/L) inhibited basal and glucose-induced insulin secretion in a concentration- dependent manner. Insulinotropic responses to alanine, arginine, 2-ketoisocaproate, elevated Ca, tolbutamide, potassium chloride (KCl), forskolin, and phorbol 12-myristate 13-acetate were also significantly reduced by homocysteine. Likewise, preincubation with homocysteine caused a reduction in the insulinotropic responses to glucose and each of the secretagogues tested. Notably, excess catalase (100 μg/mL) in the buffer, although sufficient to remove homocysteine-derived H2O2, did not alleviate the detrimental effects of homocysteine. CONCLUSIONS: Collectively, these data suggest that homocysteine impairs insulin secretory function by mechanisms independent of H2O2 generation. Although homocysteine may give rise to reactive oxygen species, these observations indicate detrimental non-oxidative pancreatic β-cell actions of homocysteine.
KW - Auto-oxidation
KW - Homocysteine
KW - Hydrogen peroxide
KW - Insulin secretion/pancreatic β-cells
UR - http://www.scopus.com/inward/record.url?scp=33846022003&partnerID=8YFLogxK
U2 - 10.1097/01.mpa.0000240613.43345.51
DO - 10.1097/01.mpa.0000240613.43345.51
M3 - Article
C2 - 17198197
AN - SCOPUS:33846022003
SN - 0885-3177
VL - 34
SP - 144
EP - 151
JO - Pancreas
JF - Pancreas
IS - 1
ER -